Disease severity during SARS-COV-2 reinfection: a nationwide study.
J Infect
; 84(4): 542-550, 2022 04.
Article
in English
| MEDLINE | ID: covidwho-1683338
ABSTRACT
OBJECTIVE:
We aimed to look at the burden of disease caused by SARS-COV-2 reinfections and identified potential risk factors for disease severity.METHODS:
We used national surveillance data to collect information on all SARS-CoV-2 primary infection and suspected reinfection cases between January 2020 until early May 2021. Reinfection cases were positive COVID-19 PCR or antigen test, 90 days after their first COVID-19 positive test. We collected information on case demographics, hospital and ICU admission, immunisation status and if individuals were at risk of complication for COVID-19.RESULTS:
Deaths reported within 28 days of testing positive were 61% (95% confidence interval 56% to 65%) lower in suspected COVID-19 reinfection than primary infection cases. In the unvaccinated cohort, reinfections were associated with 49% (37% to 58%) lower odds of hospital admission in cases aged 50 to 65 years in the population not identified at risk of complication for COVID-19, and 34% (17% to 48%) in those at risk. ICU admission at reinfection compared to primary infection decreased 76% (55% to 87%). Individuals at risk and those aged below 50 years, who received at least 1 dose of vaccine against COVID-19, were 62% (39% to 74%) and 58% (24% to 77%) less likely to get admitted to hospital at reinfection, respectively.CONCLUSION:
Prior SARS-CoV-2 infection was associated with lower odds of dying, and both prior infection and immunisation showed a protective effect against severe disease in selected populations. Older age, sex and underlying comorbidities appeared as principal risk factors for illness severity at reinfection.FUNDING:
PHE/UKHSA.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Infect
Year:
2022
Document Type:
Article
Affiliation country:
J.jinf.2022.01.012
Similar
MEDLINE
...
LILACS
LIS